# SCN11A

## Overview
The SCN11A gene encodes the sodium voltage-gated channel alpha subunit 11, also known as NaV1.9, which is a transmembrane protein primarily expressed in peripheral sensory neurons, including those in the dorsal root ganglia and trigeminal ganglia. This channel is part of the voltage-gated sodium channel family, which plays a crucial role in the generation and propagation of action potentials in neurons. NaV1.9 is particularly important in modulating pain perception and inflammatory responses due to its unique activation properties and resistance to tetrodotoxin. The channel's function is influenced by its structural components, including its voltage-sensing domains and inactivation gates, which are essential for its role in neuronal excitability and signal transmission. Mutations in SCN11A have been linked to various pain-related disorders, highlighting its significance in clinical research and potential therapeutic interventions (Catterall2012Voltage‐gated; Zhang2013GainofFunction; Phatarakijnirund2016Congenital).

## Structure
The SCN11A gene encodes the NaV1.9 voltage-gated sodium channel, which is primarily expressed in peripheral sensory neurons, including the dorsal root ganglia and trigeminal ganglia, as well as the enteric plexus (Phatarakijnirund2016Congenital). The NaV1.9 channel is a tetrodotoxin-resistant polypeptide composed of a 260 kDa α-subunit and an auxiliary β-subunit. The α-subunit consists of four homologous domains (DI-DIV), each containing six α-helical transmembrane segments (S1-S6) linked by three loops (SavioGalimberti2012VoltageGated; Phatarakijnirund2016Congenital).

The S6 segments form the walls of the sodium channel's pore, which is crucial for its function in transmitting pain signals (Phatarakijnirund2016Congenital). The channel's structure includes a voltage-sensing domain, primarily involving the S4 segments, which carry gating charges and are essential for channel activation (Catterall2012Voltage‐gated). The intracellular loop connecting domains III and IV contains the IFM motif, which acts as an inactivation gate, blocking the pore during fast inactivation (Catterall2012Voltage‐gated).

Post-translational modifications, such as phosphorylation, can regulate the function of NaV1.9, and splice variants may exist, potentially altering its functional properties (de2015Voltage-Gated). The channel's structure and function are integral to its role in pain perception and related channelopathies (SavioGalimberti2012VoltageGated).

## Function
The SCN11A gene encodes the Na v 1.9 sodium channel, which is a tetrodotoxin-resistant channel primarily expressed in nociceptive neurons of the dorsal root ganglia (DRG) and trigeminal ganglia. This channel is crucial for the generation and propagation of action potentials in these neurons, playing a significant role in pain perception by modulating sodium ion flow across cell membranes, which influences neuronal excitability and signal transmission (Zhang2013GainofFunction; Phatarakijnirund2016Congenital).

Na v 1.9 is activated by relatively negative membrane potentials and contributes to setting the membrane potential by amplifying sub-threshold depolarizations and prolonging them, although its activation kinetics are too slow to directly contribute to impulse firing (Baker2020Painful). This channel is involved in modulating pain sensitivity, as demonstrated by knockout studies in mice that show an analgesic phenotype, indicating its role in pain modulation (Zhang2013GainofFunction).

In addition to its role in pain perception, Na v 1.9 is involved in peripheral inflammatory responses, where inflammatory mediators can modulate pain hypersensitivity associated with this channel (Zhang2013GainofFunction). The channel is also expressed in the enteric plexus, where it affects gut motility by modifying the firing properties of gut afferents (Baker2020Painful).

## Clinical Significance
Mutations in the SCN11A gene, which encodes the voltage-gated sodium channel Na v 1.9, are associated with a range of pain-related disorders. Gain-of-function mutations in SCN11A can lead to familial episodic pain syndrome (FEPS), characterized by recurrent episodes of severe limb pain beginning in early childhood. These episodes are often triggered by environmental factors and can be alleviated by anti-inflammatory analgesics (Noguchi2024Genetic; Zhang2013GainofFunction). Specific mutations such as c.673C>T (p.Arg225Cys) and c.2423C>G (p.Ala808Gly) have been identified in families with this condition, leading to increased excitability of dorsal root ganglion neurons (Zhang2013GainofFunction).

Conversely, certain gain-of-function mutations in SCN11A can result in congenital insensitivity to pain (CIP), a condition where individuals do not perceive pain, leading to frequent injuries and other complications. This is due to altered activation and deactivation kinetics of the Na v 1.9 channel, which impairs pain signal transmission (Ebbinghaus2020Gainoffunction; Phatarakijnirund2016Congenital). The mutation p.Leu811Pro, for example, is associated with reduced pain sensitivity and other sensory disturbances (Ebbinghaus2020Gainoffunction). These findings underscore the critical role of SCN11A in modulating pain perception.


## References


[1. (SavioGalimberti2012VoltageGated) Eleonora Savio-Galimberti, Michael H. Gollob, and Dawood Darbar. Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies. Frontiers in Pharmacology, 2012. URL: http://dx.doi.org/10.3389/fphar.2012.00124, doi:10.3389/fphar.2012.00124. This article has 83 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2012.00124)

[2. (de2015Voltage-Gated) Manuel de Lera Ruiz and Richard L. Kraus. Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications. Journal of Medicinal Chemistry, 58(18):7093–7118, May 2015. URL: http://dx.doi.org/10.1021/jm501981g, doi:10.1021/jm501981g. This article has 377 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1021/jm501981g)

[3. (Zhang2013GainofFunction) Xiang Yang Zhang, Jingmin Wen, Wei Yang, Cheng Wang, Luna Gao, Liang Hong Zheng, Tao Wang, Kaikai Ran, Yulei Li, Xiangyang Li, Ming Xu, Junyu Luo, Shenglei Feng, Xixiang Ma, Hongying Ma, Zuying Chai, Zhuan Zhou, Jing Yao, Xue Zhang, and Jing Yu Liu. Gain-of-function mutations in scn11a cause familial episodic pain. The American Journal of Human Genetics, 93(5):957–966, November 2013. URL: http://dx.doi.org/10.1016/j.ajhg.2013.09.016, doi:10.1016/j.ajhg.2013.09.016. This article has 156 citations.](https://doi.org/10.1016/j.ajhg.2013.09.016)

[4. (Catterall2012Voltage‐gated) William A. Catterall. Voltage‐gated sodium channels at 60: structure, function and pathophysiology. The Journal of Physiology, 590(11):2577–2589, April 2012. URL: http://dx.doi.org/10.1113/jphysiol.2011.224204, doi:10.1113/jphysiol.2011.224204. This article has 542 citations.](https://doi.org/10.1113/jphysiol.2011.224204)

[5. (Baker2020Painful) Mark D. Baker and Mohammed A. Nassar. Painful and painless mutations of scn9a and scn11a voltage-gated sodium channels. Pflügers Archiv - European Journal of Physiology, 472(7):865–880, June 2020. URL: http://dx.doi.org/10.1007/s00424-020-02419-9, doi:10.1007/s00424-020-02419-9. This article has 30 citations.](https://doi.org/10.1007/s00424-020-02419-9)

[6. (Noguchi2024Genetic) Atsuko Noguchi, Tohru Tezuka, Hiroko Okuda, Hatasu Kobayashi, Kouji H. Harada, Takeshi Yoshida, Shinji Akioka, Keiko Wada, Aya Takeya, Risako Kabata-Murasawa, Daiki Kondo, Ken Ishikawa, Takeshi Asano, Michimasa Fujiwara, Nozomi Hishikawa, Tomoyuki Mizukami, Toshiaki Hitomi, Shohab Youssefian, Yoshihiro Nagai, Manabu Tanaka, Kaoru Eto, Hideaki Shiraishi, Fumimasa Amaya, Akio Koizumi, and Tsutomu Takahashi. Genetic analysis of scn11a, scn10a, and scn9a in familial episodic pain syndrome (feps) in japan and proposal of clinical diagnostic criteria. International Journal of Molecular Sciences, 25(13):6832, June 2024. URL: http://dx.doi.org/10.3390/ijms25136832, doi:10.3390/ijms25136832. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25136832)

[7. (Ebbinghaus2020Gainoffunction) Matthias Ebbinghaus, Lorena Tuchscherr, Gisela Segond von Banchet, Lutz Liebmann, Volker Adams, Mieczyslaw Gajda, Christian A. Hübner, Ingo Kurth, and Hans-Georg Schaible. Gain-of-function mutation in scn11a causes itch and affects neurogenic inflammation and muscle function in scn11a+/l799p mice. PLOS ONE, 15(8):e0237101, August 2020. URL: http://dx.doi.org/10.1371/journal.pone.0237101, doi:10.1371/journal.pone.0237101. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0237101)

[8. (Phatarakijnirund2016Congenital) Voraluck Phatarakijnirund, Steven Mumm, William H. McAlister, Deborah V. Novack, Deborah Wenkert, Karen L. Clements, and Michael P. Whyte. Congenital insensitivity to pain: fracturing without apparent skeletal pathobiology caused by an autosomal dominant, second mutation in scn11a encoding voltage-gated sodium channel 1.9. Bone, 84:289–298, March 2016. URL: http://dx.doi.org/10.1016/j.bone.2015.11.022, doi:10.1016/j.bone.2015.11.022. This article has 51 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bone.2015.11.022)